155 related articles for article (PubMed ID: 28056470)
1. [Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data].
Lappe V; Köster I; Schubert I
Dtsch Med Wochenschr; 2017 Jan; 142(1):e1-e9. PubMed ID: 28056470
[TBL] [Abstract][Full Text] [Related]
2. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
[TBL] [Abstract][Full Text] [Related]
3. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
[TBL] [Abstract][Full Text] [Related]
4. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
Lamine F; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2016; 146():w14282. PubMed ID: 26922155
[TBL] [Abstract][Full Text] [Related]
6. Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians.
Boyc KS; Yurgin N; Lage MJ
Adv Ther; 2007; 24(4):803-13. PubMed ID: 17901029
[TBL] [Abstract][Full Text] [Related]
7. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
Xu Y; Pilla SJ; Alexander GC; Murimi IB
PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
[TBL] [Abstract][Full Text] [Related]
8. Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.
Schubert I; Ihle P; Sabatowski R
Dtsch Arztebl Int; 2013 Jan; 110(4):45-51. PubMed ID: 23413387
[TBL] [Abstract][Full Text] [Related]
9. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
10. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes.
Cohen FJ; Neslusan CA; Conklin JE; Song X
Diabetes Care; 2003 Jun; 26(6):1847-51. PubMed ID: 12766121
[TBL] [Abstract][Full Text] [Related]
11. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.
Sharma M; Nazareth I; Petersen I
BMJ Open; 2016 Jan; 6(1):e010210. PubMed ID: 26769791
[TBL] [Abstract][Full Text] [Related]
13. Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015.
Lunger L; Melmer A; Oberaigner W; Leo M; Juchum M; Pölzl K; Gänzer J; Innerebner M; Eisendle E; Beck G; Kathrein H; Heindl B; Schönherr HR; Lechleitner M; Tilg H; Ebenbichler C
Wien Klin Wochenschr; 2017 Jan; 129(1-2):46-51. PubMed ID: 27909794
[TBL] [Abstract][Full Text] [Related]
14. Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
Manski-Nankervis JE; Thuraisingam S; Sluggett JK; Lau P; Blackberry I; Ilomaki J; Furler J; Bell JS
Prim Care Diabetes; 2019 Apr; 13(2):113-121. PubMed ID: 30262176
[TBL] [Abstract][Full Text] [Related]
15. Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013.
Wang T; McNeill AM; Chen Y; Senderak M; Shankar RR
J Clin Pharm Ther; 2016 Apr; 41(2):229-36. PubMed ID: 26960965
[TBL] [Abstract][Full Text] [Related]
16. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
[TBL] [Abstract][Full Text] [Related]
17. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
[TBL] [Abstract][Full Text] [Related]
18. Time trends in diabetes medication prescription and factors associated with metformin discontinuation in people with newly diagnosed type 2 diabetes: A national population-based study.
Aguadé AS; Gastaldi-Ménager C; Fontaine P; Karsenty D; Fagot-Campagna A; Amadou C
Diabet Med; 2021 Jul; 38(7):e14457. PubMed ID: 33176391
[TBL] [Abstract][Full Text] [Related]
19. Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines.
Wang TY; Eguale T; Tamblyn R
BMC Health Serv Res; 2013 Oct; 13():442. PubMed ID: 24160916
[TBL] [Abstract][Full Text] [Related]
20. Metformin utilisation in Australian community and aged care settings.
Huang W; Peterson GM; Zaidi ST; Castelino RL
Diabetes Res Clin Pract; 2015 May; 108(2):336-41. PubMed ID: 25771309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
